Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's disease

16Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

By controlling the proper folding of proteins imported into mitochondria and ensuring crosstalk between the reticulum and mitochondria to modulate intracellular calcium fluxes, Mortalin is a chaperone protein that plays crucial roles in neuronal homeostasis and activity. However, its expression and stability are strongly modified in response to cellular stresses, in particular upon altered oxidative conditions during neurodegeneration. Here, we report and discuss the abundant literature that has highlighted its contribution to the pathophysiology of Parkinson's disease, as well as its therapeutic and prognostic potential in this still incurable pathology.

Cite

CITATION STYLE

APA

Texier, B., Prime, M., Atamena, D., Belenguer, P., & Szelechowski, M. (2023, February 1). Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson’s disease. Neural Regeneration Research. Wolters Kluwer Medknow Publications. https://doi.org/10.4103/1673-5374.346487

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free